SXTP
Price
$1.01
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
14 days until earnings call
VRAX
Price
$2.14
Change
-$0.00 (-0.00%)
Updated
Nov 12 closing price
Ad is loading...

SXTP vs VRAX

Header iconSXTP vs VRAX Comparison
Open Charts SXTP vs VRAXBanner chart's image
60 Degrees Pharmaceuticals
Price$1.01
Change-$0.00 (-0.00%)
Volume$29.29K
CapitalizationN/A
Virax Biolabs Group
Price$2.14
Change-$0.00 (-0.00%)
Volume$403.81K
CapitalizationN/A
SXTP vs VRAX Comparison Chart
Loading...
SXTP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
SXTP vs. VRAX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SXTP is a Buy and VRAX is a Sell.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (SXTP: $1.01 vs. VRAX: $2.13)
Brand notoriety: SXTP and VRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SXTP: 33% vs. VRAX: 15%
Market capitalization -- SXTP: $1.81M vs. VRAX: $8.47M
SXTP [@Biotechnology] is valued at $1.81M. VRAX’s [@Biotechnology] market capitalization is $8.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SXTP’s FA Score shows that 1 FA rating(s) are green whileVRAX’s FA Score has 1 green FA rating(s).

  • SXTP’s FA Score: 1 green, 4 red.
  • VRAX’s FA Score: 1 green, 4 red.
According to our system of comparison, VRAX is a better buy in the long-term than SXTP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SXTP’s TA Score shows that 5 TA indicator(s) are bullish while VRAX’s TA Score has 3 bullish TA indicator(s).

  • SXTP’s TA Score: 5 bullish, 3 bearish.
  • VRAX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, SXTP is a better buy in the short-term than VRAX.

Price Growth

SXTP (@Biotechnology) experienced а +11.96% price change this week, while VRAX (@Biotechnology) price change was +7.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.86%. For the same industry, the average monthly price growth was +5.66%, and the average quarterly price growth was +6.44%.

Reported Earning Dates

SXTP is expected to report earnings on Nov 27, 2024.

VRAX is expected to report earnings on Aug 12, 2022.

Industries' Descriptions

@Biotechnology (-1.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRAX($8.47M) has a higher market cap than SXTP($1.81M). VRAX YTD gains are higher at: 45.890 vs. SXTP (-91.748). SXTP has higher annual earnings (EBITDA): -1.49M vs. VRAX (-6.9M). VRAX has more cash in the bank: 5.11M vs. SXTP (1.58M). SXTP has less debt than VRAX: SXTP (157K) vs VRAX (182K). SXTP has higher revenues than VRAX: SXTP (418K) vs VRAX (79.3K).
SXTPVRAXSXTP / VRAX
Capitalization1.81M8.47M21%
EBITDA-1.49M-6.9M22%
Gain YTD-91.74845.890-200%
P/E RatioN/AN/A-
Revenue418K79.3K527%
Total Cash1.58M5.11M31%
Total Debt157K182K86%
TECHNICAL ANALYSIS
Technical Analysis
SXTPVRAX
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 21 days ago
87%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
SXTP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COEP0.210.01
+4.33%
Coeptis Therapeutics Holdings
VXRT0.720.03
+4.09%
Vaxart
BANF126.50-0.02
-0.02%
BancFirst Corp
CBL27.58-0.18
-0.65%
CBL & Associates Properties
EDU58.11-1.88
-3.13%
New Oriental Education and Technology Group

SXTP and

Correlation & Price change

A.I.dvisor tells us that SXTP and RVNC have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SXTP and RVNC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SXTP
1D Price
Change %
SXTP100%
+2.02%
RVNC - SXTP
23%
Poorly correlated
+19.71%
SPHRF - SXTP
21%
Poorly correlated
N/A
OABI - SXTP
20%
Poorly correlated
-2.39%
VRAX - SXTP
20%
Poorly correlated
-11.62%
APGE - SXTP
18%
Poorly correlated
-5.14%
More

VRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRAX has been loosely correlated with ALZN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VRAX jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRAX
1D Price
Change %
VRAX100%
-11.62%
ALZN - VRAX
41%
Loosely correlated
+2.00%
SNGX - VRAX
36%
Loosely correlated
+1.67%
NCNA - VRAX
36%
Loosely correlated
+2.56%
NTRB - VRAX
31%
Poorly correlated
+3.49%
PTGX - VRAX
30%
Poorly correlated
-7.12%
More